Not classified by GICS
16 companies in this sector without a GICS sub-industry , largest first. Open any company for its filing-based history.
| # | Ticker | Company | Market cap | P/E | Dividend yield | Years of data |
|---|---|---|---|---|---|---|
| 1 | GALDY | GALDERMA GROUP AG | $49.1B | 80.6 | 0.2% | 5 |
| 2 | MMED | MiniMed Group, Inc. Common Stock | $4.29B | — | — | 4 |
| 3 | LKFT | Lakefront Biotherapeutics NV | $1.95B | 3.5 | — | 4 |
| 4 | DMRA | Damora Therapeutics, Inc. | $1.76B | — | — | 8 |
| 5 | AKTS | Aktis Oncology, Inc. Common stock | $1.54B | — | — | 11 |
| 6 | FTH | Faeth Therapeutics, Inc. | $932M | — | — | 8 |
| 7 | ODTX | Odyssey Therapeutics, Inc. Common Stock | $817M | — | — | 4 |
| 8 | AGMB | AgomAb Therapeutics NV American Depositary Shares | $644M | — | — | 4 |
| 9 | ACH | Accendra Health Inc | $262M | — | — | 12 |
| 10 | MSLE | Satellos Bioscience Inc. Common Stock | $204M | — | — | 12 |
| 11 | FOCL | EDAP TMS S.A. | $204M | — | — | 12 |
| 12 | NGEN | NervGen Pharma Corp. | $200M | — | — | 9 |
| 13 | CNTN | Canton Strategic Holdings, Inc. | $184M | — | — | 7 |
| 14 | YDES | YD Bio Ltd | $152M | — | — | 6 |
| 15 | EMPG | Empro Group Inc. Ordinary shares | $143M | 192.9 | — | 4 |
| 16 | FLNA | Filana Therapeutics, Inc. | $57M | — | — | 5 |
Market capitalization, P/E and dividend yield are the published company index's values as of 2026-07-22. Sorted by size; this is not a ranking of quality.